Skip to main content
Clinical Trials/NCT06903104
NCT06903104CompletedNot Applicable

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

Institut de Cancérologie de Lorraine1 site in 1 country20 target enrollmentStarted: March 13, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).

Study Overview

Brief Summary

The MAEva program seems to meet the challenges of implementing meditation for cancer care workers. As part of our Quality of Life and Working Conditions initiative, the investigator decided to offer it to staff at our Cancer Center. The MAEva program is delivered in a closed format: participants commit to following, as far as possible, the three sessions of the program - one session per week for 3 weeks. During the sessions, it will be proposed to train meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Before and after the program, participants will complete a quality of life evaluation, a perceived stress scale, and a questionnaire to assess psychological flexibility.

At the end of the program, each participant will be asked to complete a satisfaction questionnaire and a semi-directive interview, by videoconference, or by telephone in the event of digital impossibility with voice recording, to enable a qualitative analysis.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Participant of legal age
  • •Willingness to participate in the program - voluntary registration
  • •Commitment to attend all 3 program sessions
  • •Schedule compatible with participation in the 3 program sessions
  • •Participant has understood, signed and dated the consent form
  • •Participant affiliated to the social security system

Exclusion Criteria

  • •No desire to participate in the program - non-registration
  • •Previous participation in MAEva program
  • •No commitment to participate in the 3 program sessions
  • •Agenda incompatible with the 3 program sessions

Arms & Interventions

MAEva program is delivered in a closed format

Experimental

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Intervention: Mindfulness closed program (Other)

MAEva program is delivered in a closed format

Experimental

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Intervention: Quality of life evaluation (Diagnostic Test)

MAEva program is delivered in a closed format

Experimental

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Intervention: Perceived Stress Scale (Diagnostic Test)

MAEva program is delivered in a closed format

Experimental

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Intervention: Multidimensional Psychological Flexibility Inventory (Diagnostic Test)

MAEva program is delivered in a closed format

Experimental

MAEva program is delivered in a closed format. One session per week for 3 weeks.

Intervention: satisfaction questionnaire and semi-structured interview (Other)

Outcomes

Primary Outcomes

Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).

Time Frame: 5 weeks

Participation rate of employees at a hospital in the MAEva program and number of sessions attended (number of participants who completed the entire program)

Secondary Outcomes

  • Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.(5 weeks)

Investigators

Sponsor
Institut de Cancérologie de Lorraine
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials